Larofen Pentru Copii

Ibuprofen, the active ingredient in Larofen Pentru Copii, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral suspension for oral use. It treats pain, fever, and inflammation in children.

GNH USA supplies Larofen Pentru Copii as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is an NSAID that reduces pain, fever, and inflammation in the pediatric population.

- Pain relief: alleviates mild to moderate pain such as headache, toothache or post‑vaccination discomfort. - Fever reduction: lowers elevated body temperature associated with infections or inflammatory conditions. - Inflammation control: decreases swelling caused by minor injuries, sprains or inflammatory disorders.

Common Side Effects: - Gastrointestinal discomfort such as nausea, dyspepsia or abdominal pain. - Headache. - Dizziness. - Mild skin rash or itching.

Serious or Rare Side Effects: - Severe allergic reactions including anaphylaxis or angioedema. - Gastrointestinal bleeding, ulceration or perforation. - Elevated liver enzymes or hepatitis. - Impaired kidney function or acute renal failure.

When using Larofen Pentru Copii, consider the following precautions: - Age limitation: use only in children as directed by a healthcare professional. - Gastro‑intestinal risk: avoid in children with active ulcer disease or a history of GI bleeding. - Renal function: monitor hydration status and renal health, especially in dehydrated or febrile children. - Asthma: ibuprofen may exacerbate bronchospasm in susceptible individuals. - Concomitant anticoagulants: increased risk of bleeding when used with warfarin or similar agents. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Ibuprofen can interact with several medicines; awareness of these interactions helps minimise risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding tendency. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: increased risk of ulceration or GI bleeding. - ACE inhibitors or ARBs: potential for reduced renal perfusion.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal clearance of ibuprofen. - Lithium: ibuprofen may raise serum lithium concentrations. - Methotrexate: decreased elimination leading to toxicity.